Cargando…

N-terminal pro-B-type natriuretic peptide and outcomes in type B aortic dissection in China: a retrospective multicentre study

OBJECTIVES: N-terminal pro-B-type natriuretic peptide (NT-pro-BNP) is an unfavourable factor responsible for poor outcomes in the cardiovascular diseases. Nevertheless, the prognostic role of NT-pro-BNP in type B aortic dissection (TBAD) remains unclear. The aim of the current study was to investiga...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Changjun, Zhou, Jianwei, Xiong, Si, Kang, Zhongqiang, Zhang, Jing, Sun, Yifan, Qin, Biyun, Fang, Kuaifa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731865/
https://www.ncbi.nlm.nih.gov/pubmed/31492783
http://dx.doi.org/10.1136/bmjopen-2019-029885
_version_ 1783449747334365184
author Luo, Changjun
Zhou, Jianwei
Xiong, Si
Kang, Zhongqiang
Zhang, Jing
Sun, Yifan
Qin, Biyun
Fang, Kuaifa
author_facet Luo, Changjun
Zhou, Jianwei
Xiong, Si
Kang, Zhongqiang
Zhang, Jing
Sun, Yifan
Qin, Biyun
Fang, Kuaifa
author_sort Luo, Changjun
collection PubMed
description OBJECTIVES: N-terminal pro-B-type natriuretic peptide (NT-pro-BNP) is an unfavourable factor responsible for poor outcomes in the cardiovascular diseases. Nevertheless, the prognostic role of NT-pro-BNP in type B aortic dissection (TBAD) remains unclear. The aim of the current study was to investigate the relationship between NT-pro-BNP levels and in-hospital and long-term adverse prognosis in patients with TBAD. DESIGN: A retrospective multicentre study. SETTING: Liutie Central Hospital, Nanfang Hospital and Huiyang Hospital in China. PARTICIPANTS: A total of 657 consecutive patients with TBAD were enrolled in the study. NT-pro-BNP was measured at admission and included patients were divided into three groups according to the tertiles of NT-pro-BNP (pg/mL): <95 (n=220), 95–312 (n=218) and >312 (n=219). PRIMARY AND SECONDARY OUTCOME MEASURES: Long-term mortality and in-hospital major adverse clinical events. RESULTS: Overall, in-hospital death occurred in 27 patients (4.1%), which was significantly higher in upper tertiles of NT-pro-BNP (0.5% vs 4.1% vs 7.8%, p<0.001). The incident of in-hospital major adverse clinical events increased along with higher NT-pro-BNP (1.4% vs 11.5% vs 15.5%, p<0.001). NT-pro-BNP >210 pg/mL had 81.5% sensitivity and 58.6% specificity for predicting in-hospital death (area under the curve= 0.774, 95% CI 0.692 to 0.855; p<0.001). After a median of 3.1 years of follow-up, 97 (14.8%) patients died. The Kaplan-Meier analysis indicated that the long-term cumulative mortality was higher in patients with NT-pro-BNP >210 pg/mL compared with patients with NT-pro-BNP ≤210 pg/mL (log-rank=26.92, p<0.001). In multivariable Cox survival modelling, NT-pro-BNP >210 pg/mL was independently associated with long-term death (adjusted HR 2.47, 95% CI 1.45 to 4.22, p=0.001). CONCLUSIONS: NT-pro-BNP resulted as an independent predictor of adverse prognosis in patients with TBAD, thus could be used as a potential risk-stratification tool.
format Online
Article
Text
id pubmed-6731865
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-67318652019-09-20 N-terminal pro-B-type natriuretic peptide and outcomes in type B aortic dissection in China: a retrospective multicentre study Luo, Changjun Zhou, Jianwei Xiong, Si Kang, Zhongqiang Zhang, Jing Sun, Yifan Qin, Biyun Fang, Kuaifa BMJ Open Cardiovascular Medicine OBJECTIVES: N-terminal pro-B-type natriuretic peptide (NT-pro-BNP) is an unfavourable factor responsible for poor outcomes in the cardiovascular diseases. Nevertheless, the prognostic role of NT-pro-BNP in type B aortic dissection (TBAD) remains unclear. The aim of the current study was to investigate the relationship between NT-pro-BNP levels and in-hospital and long-term adverse prognosis in patients with TBAD. DESIGN: A retrospective multicentre study. SETTING: Liutie Central Hospital, Nanfang Hospital and Huiyang Hospital in China. PARTICIPANTS: A total of 657 consecutive patients with TBAD were enrolled in the study. NT-pro-BNP was measured at admission and included patients were divided into three groups according to the tertiles of NT-pro-BNP (pg/mL): <95 (n=220), 95–312 (n=218) and >312 (n=219). PRIMARY AND SECONDARY OUTCOME MEASURES: Long-term mortality and in-hospital major adverse clinical events. RESULTS: Overall, in-hospital death occurred in 27 patients (4.1%), which was significantly higher in upper tertiles of NT-pro-BNP (0.5% vs 4.1% vs 7.8%, p<0.001). The incident of in-hospital major adverse clinical events increased along with higher NT-pro-BNP (1.4% vs 11.5% vs 15.5%, p<0.001). NT-pro-BNP >210 pg/mL had 81.5% sensitivity and 58.6% specificity for predicting in-hospital death (area under the curve= 0.774, 95% CI 0.692 to 0.855; p<0.001). After a median of 3.1 years of follow-up, 97 (14.8%) patients died. The Kaplan-Meier analysis indicated that the long-term cumulative mortality was higher in patients with NT-pro-BNP >210 pg/mL compared with patients with NT-pro-BNP ≤210 pg/mL (log-rank=26.92, p<0.001). In multivariable Cox survival modelling, NT-pro-BNP >210 pg/mL was independently associated with long-term death (adjusted HR 2.47, 95% CI 1.45 to 4.22, p=0.001). CONCLUSIONS: NT-pro-BNP resulted as an independent predictor of adverse prognosis in patients with TBAD, thus could be used as a potential risk-stratification tool. BMJ Publishing Group 2019-09-05 /pmc/articles/PMC6731865/ /pubmed/31492783 http://dx.doi.org/10.1136/bmjopen-2019-029885 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Cardiovascular Medicine
Luo, Changjun
Zhou, Jianwei
Xiong, Si
Kang, Zhongqiang
Zhang, Jing
Sun, Yifan
Qin, Biyun
Fang, Kuaifa
N-terminal pro-B-type natriuretic peptide and outcomes in type B aortic dissection in China: a retrospective multicentre study
title N-terminal pro-B-type natriuretic peptide and outcomes in type B aortic dissection in China: a retrospective multicentre study
title_full N-terminal pro-B-type natriuretic peptide and outcomes in type B aortic dissection in China: a retrospective multicentre study
title_fullStr N-terminal pro-B-type natriuretic peptide and outcomes in type B aortic dissection in China: a retrospective multicentre study
title_full_unstemmed N-terminal pro-B-type natriuretic peptide and outcomes in type B aortic dissection in China: a retrospective multicentre study
title_short N-terminal pro-B-type natriuretic peptide and outcomes in type B aortic dissection in China: a retrospective multicentre study
title_sort n-terminal pro-b-type natriuretic peptide and outcomes in type b aortic dissection in china: a retrospective multicentre study
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731865/
https://www.ncbi.nlm.nih.gov/pubmed/31492783
http://dx.doi.org/10.1136/bmjopen-2019-029885
work_keys_str_mv AT luochangjun nterminalprobtypenatriureticpeptideandoutcomesintypebaorticdissectioninchinaaretrospectivemulticentrestudy
AT zhoujianwei nterminalprobtypenatriureticpeptideandoutcomesintypebaorticdissectioninchinaaretrospectivemulticentrestudy
AT xiongsi nterminalprobtypenatriureticpeptideandoutcomesintypebaorticdissectioninchinaaretrospectivemulticentrestudy
AT kangzhongqiang nterminalprobtypenatriureticpeptideandoutcomesintypebaorticdissectioninchinaaretrospectivemulticentrestudy
AT zhangjing nterminalprobtypenatriureticpeptideandoutcomesintypebaorticdissectioninchinaaretrospectivemulticentrestudy
AT sunyifan nterminalprobtypenatriureticpeptideandoutcomesintypebaorticdissectioninchinaaretrospectivemulticentrestudy
AT qinbiyun nterminalprobtypenatriureticpeptideandoutcomesintypebaorticdissectioninchinaaretrospectivemulticentrestudy
AT fangkuaifa nterminalprobtypenatriureticpeptideandoutcomesintypebaorticdissectioninchinaaretrospectivemulticentrestudy